Acellular Exponential Or Geometric Amplification (e.g., Pcr, Etc.) Patents (Class 435/91.2)
-
Patent number: 10106845Abstract: A two-step multiplex amplification reaction includes a first step which truncates the standard initial multiplex amplification round to “boost” the sample copy number by only a 100-1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid. In particular, nucleic acid sequences that uniquely identify E. Coli were identified using the multiplex amplification method.Type: GrantFiled: October 14, 2016Date of Patent: October 23, 2018Assignee: Applied Biosystems, LLCInventors: John Gerdes, Elaine Best, Jeffrey M. Marmaro
-
Patent number: 10100348Abstract: The present invention provides a simple and rapid method for preparing purified transposase complexes that are highly suited for fragmenting DNA. The method includes forming transposase complexes with oligonucleotide adapters in cell lysate, then purifying the complexes from the other substance in the cell lysate. Purification is accomplished using a specific binding pair, in which one member of the pair is bound to an oligonucleotide adapter of the complex and the other member of the pair is bound to a solid substrate. The bound complexes can be immediately used in DNA fragmentation reactions to produce solid substrate-bound DNA fragments, which can be used for any number of purposes, including as templates for amplification and sequencing.Type: GrantFiled: November 10, 2016Date of Patent: October 16, 2018Assignee: Agilent Technologies, Inc.Inventor: Alexander S. Belyaev
-
Patent number: 10093908Abstract: The present invention features novel, diverse, hybrid and engineered recombinase enzymes, and the utility of such proteins with associated recombination factors for carrying out DNA amplification assays. The present invention also features different recombinase ‘systems’ having distinct biochemical activities in DNA amplification assays, and differing requirements for loading factors, single-stranded DNA binding proteins (SSBs), and the quantity of crowding agent employed.Type: GrantFiled: December 19, 2013Date of Patent: October 9, 2018Assignee: Alere San Diego, Inc.Inventors: Olaf Piepenburg, Niall A. Armes, Mathew James David Parker
-
Patent number: 10081843Abstract: Animal husbandry has always been susceptible to the ravages of pathogenic infections. Poultry flus and cattle diseases are but two examples that have dire consequences for animals and adversely affect the economic fortunes of farmers. A testing and culling methodology is presented that can eliminate pathogens from an infected herd. The sensitivity of PCR to detect very low levels of nucleic acid of an infecting pathogen is utilized to identify infected animals. In addition, it has been discovered that PCR analysis of manure samples can accurately identify infected animals and offspring for those species that consume placental remains after birth. Mink Aleutian Disease Virus (mADV) is one of several deadly DNA parvoviruses that can quickly reach epidemic proportions in a mink herd. PCR primers have been developed that generate amplicons to detect and identify the mADV. In addition, a previously unidentified strain of mADV has been discovered, genomically sequenced, and substantially detailed.Type: GrantFiled: August 13, 2010Date of Patent: September 25, 2018Inventors: Mark Stahl, John Stahl, Richard Stahl
-
Patent number: 10081836Abstract: Methods, compositions, and systems are provided that allow for reliable sequencing of the initial sequence region of a sequence of interest. The methods of the invention allow for more reliable barcoding of subpopulations of nucleic acids to be sequenced.Type: GrantFiled: July 15, 2016Date of Patent: September 25, 2018Assignee: Pacific Biosciences of California, Inc.Inventors: Tyson A. Clark, Jonas Korlach, Cheryl Heiner, Kevin Travers, Erik Miller
-
Patent number: 10077470Abstract: The present disclosure provides compositions, methods and systems for sequencing a template nucleic acid using a polymerase based, nucleic acid binding reaction involving examination of the interaction between a polymerase and template nucleic acid in the presence of one or more unlabeled nucleotides. The methods rely, in part, on identifying a base of a template nucleic acid during nucleic acid synthesis by controlling the sequencing reaction conditions. Template nucleic acid bases may be identified during an examination step followed by an optional incorporation step.Type: GrantFiled: July 21, 2015Date of Patent: September 18, 2018Assignee: OMNIOME, INC.Inventors: Kandaswamy Vijayan, Eugene Tu, Mark A. Bernard
-
Patent number: 10077481Abstract: Animal husbandry has always been susceptible to the ravages of pathogenic infections. Poultry flus and cattle diseases are but two examples that have dire consequences for animals and adversely affect the economic fortunes of farmers. A testing and culling methodology is presented that can eliminate pathogens from an infected herd. The sensitivity of PCR to detect very low levels of nucleic acid of an infecting pathogen is utilized to identify infected animals. In addition, it has been discovered that PCR analysis of manure samples can accurately identify infected animals and offspring for those species that consume placental remains after birth. Mink Aleutian Disease Virus (mADV) is one of several deadly DNA parvoviruses that can quickly reach epidemic proportions in a mink herd. PCR primers have been developed that generate amplicons to detect and identify the mADV. In addition, a previously unidentified strain of mADV has been discovered, genomically sequenced, and substantially detailed.Type: GrantFiled: August 13, 2010Date of Patent: September 18, 2018Inventors: Mark Stahl, John Stahl, Richard Stahl
-
Patent number: 10077459Abstract: Methods for in vitro transcription and translation from an RCA product are provided. The methods comprise providing a double-stranded RCA product, wherein the double-stranded RCA product consists essentially of tandem repeats of a minimalistic expression sequence. The methods further comprise expressing a protein from the double-stranded RCA product in a cell-free expression system.Type: GrantFiled: May 4, 2016Date of Patent: September 18, 2018Assignee: GENERAL ELECTRIC COMPANYInventors: John Richard Nelson, Robert Scott Duthie, Erik Leeming Kvam, Wei Gao
-
Patent number: 10053725Abstract: Methods, reagents, compositions, and kits for in situ interaction determination (ISID) via interaction-dependent polymerase chain reaction (ID-PCR) are provided herein. ISID technology is useful for rapidly evaluating potential small molecule-target interactions from mixtures in a single solution. ISID is compatible with unpurified targets in biological samples and can be used to evaluate ligand-binding in DNA-encoded chemical libraries in cell lysates. ISID is also useful to screen ligand interactions of proteins or other molecules in their native state, including their native post-translational modifications and any interactions with accessory proteins and metabolites, in ways that better reflect their relevant biological environment. Because ISID is compatible with crude cell lysates, difficult-to-purify, poorly soluble, intrinsically unstable, and aggregation-prone targets may also be compatible with this method, without requiring truncation or other strategies used to promote heterologous expression.Type: GrantFiled: April 23, 2014Date of Patent: August 21, 2018Assignee: President and Fellows of Harvard CollegeInventors: David R. Liu, Lynn Marie McGregor, David Gorin, Christoph Erich Dumelin
-
Patent number: 10053728Abstract: Devices, containers, and methods are provided for performing biological analysis in a closed environment. Illustrative biological analyzes include high density nucleic acid amplification and detection and immune-PCR.Type: GrantFiled: July 16, 2015Date of Patent: August 21, 2018Assignee: BioFire Diagnostics, LLCInventors: Kirk M. Ririe, Mark Aaron Poritz
-
Patent number: 10034951Abstract: Provided herein, among other things, is a method for producing an RNA product that has reduced immunogenicity without requiring removal of any dsRNA from the RNA product. In some embodiments, the method involves transcribing a template DNA with a thermostable RNA polymerase at a temperature of greater than 44° C.Type: GrantFiled: November 22, 2017Date of Patent: July 31, 2018Assignee: New England Biolabs, Inc.Inventors: Bijoyita Roy, G. B. Robb
-
Patent number: 10036062Abstract: Provided is a primer middle sequence interference PCR method, and the method uses one segment of a non-complemented or same-sequence base of the middle sequence of primers to perform antisense interference inside and outside the primer molecules, so as to competitively destroy the polymerization among the primers to selectively inhibit amplification of the primer dimer (PD).Type: GrantFiled: November 28, 2013Date of Patent: July 31, 2018Assignee: BEIJING TAG-ARRAY MOLECULAR TEST CO., LTD.Inventors: Hong Jiang, Suwen Yue, Tongbing Liao, Bisheng Jiang, Yue Qu, Yukang Jiang
-
Patent number: 10030278Abstract: The invention relates to a method of identifying a specific yeast species in patient tissue or body fluid. The method comprises the steps of extracting and recovering DNA of the yeast species from the patient tissue or body fluid, amplifying the DNA, hybridizing a probe to the DNA to specifically identify the yeast species, and specifically identifying the yeast species. The invention also relates to a method of identifying a yeast mycotoxin in patient tissue or body fluid. The method comprises the steps of extracting and recovering the yeast mycotoxin from the patient tissue or body fluid, contacting the yeast mycotoxin with an antibody directed against the yeast mycotoxin, and identifying the yeast myocotoxin. Both of these methods can he used to determine if a patient is at risk for or has developed a disease state related to a yeast infection, and to develop an effective treatment regimen for the patient.Type: GrantFiled: October 12, 2016Date of Patent: July 24, 2018Assignee: ADVATECT DIAGNOSTICS, LLCInventor: Dennis G. Hooper
-
Patent number: 10030270Abstract: The present application relates to K-ras mutations, to polynucleotides encoding mutant K-ras polypeptides, and to methods of identifying K-ras mutations. The present application also relates to methods of diagnosing cancer; and methods and kits for predicting the usefulness of anti-EGFr specific binding agents in the treatment of tumors.Type: GrantFiled: June 14, 2012Date of Patent: July 24, 2018Assignee: AMGEN, INCInventors: Daniel Freeman, Todd Juan, Robert Radinsky
-
Patent number: 10023895Abstract: A system for automated microorganism identification and antibiotic susceptibility testing comprising a reagent cartridge, a reagent stage, a cassette, a cassette, stage, a pipettor assembly, an optical detection system, and a controller is disclosed. The system is designed to dynamically adjust motor idle torque to control heat load and employs a fast focus process for determining the true focus position of an individual microorganism. The system also may quantify the relative abundance of viable microorganisms in a sample using dynamic dilution, and facilitate growth of microorganisms in customized media for rapid, accurate antimicrobial susceptibility testing.Type: GrantFiled: March 30, 2016Date of Patent: July 17, 2018Assignee: Accelerate Diagnostics, Inc.Inventors: William L. Richards, Austin Ashby, Matthew Ketterer, Kevin Marshall, Josh Harrison, Matthew Mette, Paul Richards, Wayne Showalter, Jasmin Cote, Phillip C. Halbert, Solene Bourgeois, Steven W. Metzger, Ken Hance, Meghan Mensack, Carlos Michel, Elke Allers, Dulini Gamage, Landon Prisbrey, Oleg Gusyatin, Alena Shamsheyeva, Ben Turng, Andrew Ghusson, Kurt Reinhardt
-
Patent number: 10023867Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoral or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.Type: GrantFiled: February 21, 2013Date of Patent: July 17, 2018Assignee: BIOGENERA S.P.A.Inventors: Roberto Tonelli, Leonardo Venturelli, Andrea Tortori, Luca Montemurro
-
Patent number: 10023906Abstract: Provided in the present invention are a method for constructing a nucleic acid single-stranded cyclic library and reagent kit thereof. The method comprises the steps of using a transposase embedding complex to randomly break nucleic acids and connect a first linker; connecting a second linker at a gap; performing a first PCR reaction, wherein the 5? end of one of the primers has a first affinity tag, resulting in a product with two ends connected to different linker sequences; binding the product to a solid vector having a second affinity tag; degenerating and separating single strands having no affinity tag; and cyclizing the single strands.Type: GrantFiled: October 14, 2014Date of Patent: July 17, 2018Assignee: MGI Tech Co., Ltd.Inventors: Chunyu Geng, Rongrong Guo, Ruoying Chen, Lingyu He, Wenwei Zhang, Hui Jiang
-
Patent number: 10011868Abstract: Methods, reagents, compositions, and kits for reactivity-dependent polymerase chain reaction (RD-PCR) and interaction-dependent polymerase chain reaction (ID-PCR) are provided herein. RD-PCR is a technique useful for determining whether a reactive moiety can form a covalent bond to a target reactive moiety, for example, in screening a library of candidate reactive moieties for reactivity with a target reactive moiety, and in identifying an enzyme substrate, for example, in protease substrate profiling. ID-PCR is a technique useful for determining whether a ligand can non-covalently bind to a target molecule, for example, in screening a library of candidate ligands for non-covalent interaction with a target molecule. RD-PCR and ID-PCR are also useful in detecting the presence of an analyte or an environmental condition.Type: GrantFiled: November 3, 2015Date of Patent: July 3, 2018Assignee: President and Fellows of Harvard CollegeInventors: David R. Liu, David Gorin, Adam Kamlet, Lynn Marie McGregor, Christoph Erich Dumelin
-
Patent number: 10006081Abstract: The invention relates to a method of preparing a 5? and 3? modified library of template polynucleotides and also the use of the 5? and 3? modified library of templates in methods of solid-phase nucleic acid amplification. In particular, the invention relates to a method of preparing a 5? and 3? modified library of template polynucleotides which have common sequences at their 5? ends and at their 3? ends, wherein over-representation of “end” sequences of the primary polynucleotide molecules from when the 5? and 3? modified library is generated is greatly reduced or prevented.Type: GrantFiled: March 24, 2015Date of Patent: June 26, 2018Assignee: ILLUMINA CAMBRIDGE LIMITEDInventors: Roberto Rigatti, Niall Anthony Gormley, Helen Rachel Bignell
-
Patent number: 9982272Abstract: Mutant photosynthetic microorganisms having reduced chlorophyll and increased photosynthetic efficiency are provided. The mutants have a locked in high light-acclimated phenotype, in which many of the photosynthetic parameters characteristic of high light acclimated wild type cells are found in the LIHLA mutants when acclimated to low light, such as reduced chlorophyll, reduced NPQ, higher qP, higher Ek, higher Pmax per unit chlorophyll with little to no reduction in Pmax per cell, and higher rates of electron transport through photosystem II over a wide range of light intensities. Provided herein are constructs for attenuating or disrupting genes are provided for generating mutants having the LIHLA phenotype. Also provided are methods of culturing LIHLA mutants for the production of biomass or other products.Type: GrantFiled: December 6, 2013Date of Patent: May 29, 2018Assignee: Synthetic Genomics, Inc.Inventors: Shaun Bailey, Jay McCarren, Soyan Leung Lieberman, Jonathan E. Meuser, Anna E. Romano, Daniel Yee, Leah Soriaga, Robert C. Brown, Ariel S. Schwartz
-
Patent number: 9968928Abstract: A fluidic testing system is presented that includes a plurality of test chambers, a plurality of inlet channels, and a fluidic network that connects the inlet channels to one or more other chambers. The plurality of test chambers are each characterized by a length and a hydraulic diameter. The length of each test chamber is aligned substantially parallel to a gravity vector. Each of the test chambers has only one opening disposed along the length of the corresponding test chamber. Additionally, each of the test chambers is coupled via its respective opening to only one of the plurality of inlet channels.Type: GrantFiled: June 18, 2015Date of Patent: May 15, 2018Assignee: STAT-Diagnostica & Innovation, S.L.Inventors: Rafael Bru Gibert, Jordi Carrera Fabra, Anna Comengés Casas, José Antonio Garcia Sánchez
-
Patent number: 9970068Abstract: The invention relates to improved methods and compositions for the nucleic acid amplification of one or multiple variants (strains) of Human Immunodeficiency Virus (HIV) present in a sample, and preferably in a sample from a pathogen infected individual. In particular, novel primers, methods and kits for the amplification of one or more species of HIV Rev, Gag and Nef nucleic acids are provided. The amplified HIV nucleic acid can be used to identify and/or quantitate HIV variants present in a sample. Nucleic acids produced by the methods of the invention or the proteins encoded thereby can also be used directly as vaccines or to transfect/load antigen presenting cells. The loaded antigen presenting cells can be used as a vaccine for the treatment or prevention of HIV infection.Type: GrantFiled: May 24, 2012Date of Patent: May 15, 2018Assignee: Argos Therapeutics, Inc.Inventors: Irina Tcherepanova, Aijing Starr, Brad Lackford
-
Patent number: 9963687Abstract: This disclosure provides, among other things, a composition comprising: comprising a fusion protein comprising: (a) a DNA polymerase; and (b) a heterologous sequence-specific DNA binding domain. A method for copying a DNA template, as well as a kit for performing the same, are also described.Type: GrantFiled: February 17, 2016Date of Patent: May 8, 2018Assignee: New England Biolabs, Inc.Inventors: Pei-Chung Hsieh, Luo Sun, Thomas C. Evans, Jr., Theodore B. Davis, Andrew Gardner
-
Patent number: 9957549Abstract: The present invention provides methods, compositions and kits for the generation of next generation sequencing (NGS) libraries in which non-desired nucleic acid sequences have been depleted or substantially reduced. The methods, compositions and kits provided herein are useful, for example, for the production of libraries from total RNA with reduced ribosomal RNA and for the reduction of common mRNA species in expression profiling from mixed samples where the mRNAs of interest are present at low levels. The methods of the invention can be employed for the elimination of non-desired nucleic acid sequences in a sequence-specific manner, and consequently, for the enrichment of nucleic acid sequences of interest in a nucleic acid library.Type: GrantFiled: March 15, 2013Date of Patent: May 1, 2018Assignee: NUGEN TECHNOLOGIES, INC.Inventors: Christopher Armour, Doug Amorese, Bin Li, Nurith Kurn
-
Patent number: 9951380Abstract: The present invention provides methods, compositions, kits, systems and apparatus that are useful for multiplex PCR of one or more nucleic acids present in a sample. In particular, various target-specific primers are provided that allow for the selective amplification of one or more target sequences. In one aspect, the invention relates to target-specific primers useful for the selective amplification of one or more target sequences associated with cancer or inherited disease. In some aspects, amplified target sequences obtained using the disclosed methods, kits, systems and apparatuses can be used in various downstream processes including nucleic acid sequencing and used to detect the presence of genetic variants.Type: GrantFiled: July 9, 2015Date of Patent: April 24, 2018Assignee: LIFE TECHNOLOGIES CORPORATIONInventors: John Leamon, Mark Andersen, Michael Thornton
-
Patent number: 9951378Abstract: The present disclosure is directed to compositions, methods and kits for amplifying target nucleic acids while reducing non-specific amplification and undesired amplification products using a dual hot start reaction mixture that comprise at least two different hot start mechanisms.Type: GrantFiled: June 14, 2013Date of Patent: April 24, 2018Assignee: Life Technologies CorporationInventors: Carole Bornarth, Michael Lau, Junko Stevens
-
Patent number: 9951320Abstract: Disclosed are DNA polymerases having increased reverse transcriptase efficiency relative to a corresponding, unmodified polymerase. The polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the DNA polymerases.Type: GrantFiled: July 28, 2016Date of Patent: April 24, 2018Assignee: Roche Molecular Systems, Inc.Inventors: Keith Bauer, Thomas W. Myers, Shawn Suko
-
Patent number: 9925510Abstract: Methods and apparatus relate to the synthesis of high fidelity polynucleotides and to the reduction of sequence errors generated during synthesis of nucleic acids on a solid support. Specifically, design of support-bound template oligonucleotides is disclosed. Assembly methods include cycles of annealing, stringent wash and extension of polynucleotides comprising a sequence region complementary to immobilized template oligonucleotides. The error free synthetic nucleic acids generated therefrom can be used for a variety of applications, including synthesis of biofuels and value-added pharmaceutical products.Type: GrantFiled: November 20, 2015Date of Patent: March 27, 2018Assignee: Gen9, Inc.Inventors: Joseph Jacobson, Larry Li-Yang Chu
-
Patent number: 9925536Abstract: A device comprising a rigid substrate, a flexible cover element at least partially covering the substrate, a first structure formed in the substrate, adapted for accommodating liquids and adapted for releasing contents of one or more cells, spores, or viruses, the contents including the target molecules, a second structure formed in the substrate, adapted for accommodating liquids and comprising at least one binding member adapted for capturing the target molecules and for determining a value indicative for the presence and/or amount of the target molecules, a microfluidic network interconnecting at least the first structure and the second structure, and an actuator member adapted for effecting a fluid flow between the first structure and the second structure by pressing the flexible cover element against the substrate to selectively close a portion of the microfluidic network.Type: GrantFiled: July 23, 2008Date of Patent: March 27, 2018Assignee: CLONDIAG GMBHInventors: Eugen Ermantraut, Thomas Kaiser, Torsten Schulz, Katrin Steinmetzer, Thomas Ullrich
-
Patent number: 9920366Abstract: Disclosed herein in are methods and systems for determining genetic variants (e.g., copy number variation) in a polynucleotide sample. A method for determining copy number variations includes tagging double-stranded polynucleotides with duplex tags, sequencing polynucleotides from the sample and estimating total number of polynucleotides mapping to selected genetic loci. The estimate of total number of polynucleotides can involve estimating the number of double-stranded polynucleotides in the original sample for which no sequence reads are generated. This number can be generated using the number of polynucleotides for which reads for both complementary strands are detected and reads for which only one of the two complementary strands is detected.Type: GrantFiled: September 22, 2015Date of Patent: March 20, 2018Assignee: Guardant Health, Inc.Inventors: Helmy Eltoukhy, AmirAli Talasaz
-
Patent number: 9920385Abstract: Probes and primers are disclosed for detecting a C. glabrata resistant to an echinocandin in a sample. Method are also disclosed that utilize these probes and primers, wherein the methods can be used to detect a C. glabrata resistant to an echinocandin in a sample.Type: GrantFiled: October 5, 2015Date of Patent: March 20, 2018Assignee: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human ServicesInventors: Cau Dinh Pham, Shawn Robert Lockhart
-
Patent number: 9909122Abstract: This disclosure provides for compositions and methods for the use of nucleic acid-targeting nucleic acids and complexes thereof.Type: GrantFiled: December 21, 2015Date of Patent: March 6, 2018Assignee: Caribou Biosciences, Inc.Inventors: Andrew Paul May, Rachel E. Haurwitz, Jennifer A. Doudna, James M. Berger, Matthew Merrill Carter, Paul Donohoue
-
Patent number: 9909168Abstract: The present invention relates to an oligonucleotide having a novel structure and a method of synthesizing nucleic acid by using the same as a primer. This oligonucleotide is provided at the 5?-side of the primer with a nucleotide sequence substantially the same as a region synthesized with this primer as the origin of synthesis. The present invention realizes synthesis of nucleic acid based on an isothermal reaction with a simple constitution of reagents. Further, the present invention provides a method of synthesizing highly specific nucleic acid on the basis of this method of synthesizing nucleic acid.Type: GrantFiled: December 9, 2008Date of Patent: March 6, 2018Assignee: EIKEN KAGAKU KABUSHIKI KAISHAInventors: Tsugunori Notomi, Tetsu Hase
-
Patent number: 9890433Abstract: Disclosed are nucleic acid oligomers, including amplification oligomers, capture probes, and detection probes, for detection of a human papillomavirus (HPV) nucleic acid. Also disclosed are methods of specific nucleic acid amplification and detection using the disclosed oligomers, as well as corresponding reaction mixtures and kits.Type: GrantFiled: October 11, 2013Date of Patent: February 13, 2018Assignee: GEN-PROBE INCORPORATEDInventor: Astrid R. W. Schroder
-
Patent number: 9873909Abstract: The invention provides methods and apparatus for carrying out multiple amplification reactions in a single reaction chamber by successive cycles of loading reaction mixture, amplifying, and removing spent reaction mixture in a fluidly closed reaction system. In particular, the present invention allows amplification of a plurality of target polynucleotides from a single sample by carrying out under closed-loop control successive amplifications of different target polynucleotides from different portions of the sample.Type: GrantFiled: November 25, 2014Date of Patent: January 23, 2018Assignee: CepheidInventors: Joseph H. Smith, David H. Persing, Alan Wortman, Ronald Chang, David Swenson
-
Patent number: 9868995Abstract: The present invention provides a PCR based method for detecting chronic gastritis causing bacterium, namely Helicobacter pylori, in a stool sample. The present invention is based on the use of oligonucleotide primers and probes specific to H. pylori 23S rRNA gene.Type: GrantFiled: December 5, 2013Date of Patent: January 16, 2018Assignee: AMPLIDIAG OYInventors: Juha Kirveskari, Hilpi Rautelin
-
Patent number: 9861985Abstract: The present invention, in one aspect, provides methods and systems for controlling slugs using temperature dependent fluorescent dyes. In some embodiments, the present invention uses one or more techniques to enhance the visibility of slugs, enhance a system's ability to differentiate between slugs, and enhance a system's ability to identify the positions of slugs.Type: GrantFiled: August 31, 2011Date of Patent: January 9, 2018Assignee: Canon U.S. Life Sciences, Inc.Inventors: Johnathan S. Coursey, Kenton C. Hasson, Sami Kanderian, Gregory H. Owen, Hongye Liang, Scott Corey, Brian Bean
-
Patent number: 9855553Abstract: A fluidic testing system is presented that includes a plurality of test chambers, a plurality of inlet channels, and a fluidic network that connects the inlet channels to one or more other chambers. The plurality of test chambers are each characterized by a length and a hydraulic diameter. The length of each test chamber is aligned substantially parallel to a gravity vector. Each of the test chambers has only one opening disposed along the length of the corresponding test chamber. Additionally, each of the test chambers is coupled via its respective opening to only one of the plurality of inlet channels.Type: GrantFiled: June 18, 2015Date of Patent: January 2, 2018Assignee: Stat-Diagnostica & Innovation, S.L.Inventors: Rafael Bru Gibert, Jordi Carrera Fabra, Anna Comengés Casas, José Antonio Garcia Sánchez
-
Patent number: 9850481Abstract: The present invention provides methods to produce a reduced representation of a genome for sequencing and DNA polymorphism detection. In particular, the invention provides PCR-based methods, with normalization of the amplified products using a duplex-specific nuclease, in order to reduce over-representation of PCR products. Oligonucleotides for use in the disclosed method are also provided.Type: GrantFiled: November 25, 2014Date of Patent: December 26, 2017Assignee: University of Florida Research Foundation, Inc.Inventors: Matias Kirst, Marcio Fernando Ribeiro De Resende, Jr., Leandro Gomide Neves, Christopher Dervinis, Kelly Mayrink Balmant
-
Patent number: 9816132Abstract: A heating mechanism for use in DNA applications such as DNA amplification, extraction and sterilization is provided. Nanoparticles having photo-thermal properties are put in contact with a reaction mixture and irradiated with an activation light beam to activate these photo-thermal properties, thereby releasing heat. Nanoparticles of several types may be used. Use of the same nanoparticles or of different one to monitor the reaction using a different light beam is also presented.Type: GrantFiled: July 16, 2013Date of Patent: November 14, 2017Inventors: Philip Roche, Andrew Kirk, Lenore Beitel, Miltiadis Paliouras, Mark Trifiro, Vamsy Chodavarapu, Mohamed Najih, Joachim Thiemann
-
Patent number: 9783844Abstract: An object of the present invention is to provide methods for amplifying and detecting a nucleic acid that allow efficient hybridization, and devices and kits for use in the methods. The present invention includes amplifying a target nucleic acid into a double-stranded nucleic acid having a single-stranded region at each end, and detecting this nucleic acid. The present invention also provides detection devices and kits that make use of these methods.Type: GrantFiled: April 26, 2013Date of Patent: October 10, 2017Assignee: Kaneka CorporationInventors: Koji Takahashi, Shigehiko Miyamoto, Takaaki Jikihara, Sotaro Sano, Jun Tomono
-
Patent number: 9777316Abstract: What is described is a method for quantitative and qualitative analysis of complex template nucleic acids to be analyzed. The method comprises the co-amplification of a control nucleic acid with the complex template nucleic acid by means of isothermal strand displacement reaction. The method of the invention further comprises the determination of the amount of amplified control nucleic acid as measure for the determination of the quantity and/or quality of the complex template nucleic acid used. The present invention also relates to a kit for carrying out a method of the invention. Furthermore, the use of the method of the invention or the kit of the invention for standardization of whole-genome, whole-transcriptome and whole-bisulfitome analyses is described.Type: GrantFiled: June 3, 2010Date of Patent: October 3, 2017Assignee: QIAGEN STRASSE 1Inventors: Christian Korfhage, Evelyn Fisch
-
Patent number: 9771575Abstract: The present disclosure provides methods for barcoding a plurality of DNA samples using a microarray of barcode-containing transposase complexes. In some embodiments, the DNA samples and transposase complexes are present in aqueous droplets on the surfaces of opposing substrates, which allows a single DNA sample droplet to be combined with a single transposase-complex droplet. The barcoded DNA in the combined droplets can be used for any number of purposes, including as templates for amplification and sequencing.Type: GrantFiled: June 19, 2015Date of Patent: September 26, 2017Assignee: Agilent Technologies, Inc.Inventors: Alexander Belyaev, Nicholas M. Sampas, Alicia Scheffer-Wong
-
Patent number: 9758813Abstract: Modified double-stranded oligonucleotides that have terminal regions on each of their strands, that have a hybrid length of 6-50 nucleotides long, that have a melting temperature Tm of at least 32° C., and that include 2-4 modifying groups, each covalently attached to a different terminal region, preferably to a terminal nucleotide, said modifying groups being polycyclic substituents that do not have bulky portions that are non-planar, said modified oligonucleotide being capable of binding to the 5? exonuclease domains of DNA polymerases and, when included in a PCR or other primer-dependent DNA amplification reaction at a concentration, generally not more than 2000 nM, that is effective for at least one of the functions of suppressing mispriming, increasing polymerase selectivity against 3? terminal mismatches.Type: GrantFiled: May 18, 2015Date of Patent: September 12, 2017Assignee: Brandeis UniversityInventors: Lawrence J. Wangh, John E. Rice, Nicholas Rice, Yanwei Jia
-
Patent number: 9745627Abstract: Efficient methods are disclosed for the high throughput identification of mutations in genes in members of mutagenized populations. The methods comprise DNA isolation, pooling, amplification, creation of libraries, high throughput sequencing of libraries, preferably by sequencing-by-synthesis technologies, identification of mutations and identification of the member of the population carrying the mutation and identification of the mutation.Type: GrantFiled: February 16, 2017Date of Patent: August 29, 2017Assignee: Keygene N.V.Inventors: Michael Josephus Theresia van Eijk, Adrianus Johannes van Tunen
-
Patent number: 9738873Abstract: The nuclear reprogramming of somatic cells with mRNA encoding reprogramming factors is shown to be greatly accelerated by activation of innate immune responses in the somatic cell. Methods of activating innate immunity include activation of PKR, of toll-like receptors, e.g. TLR3, etc. In some embodiments the mRNA provides the activator of innate immunity.Type: GrantFiled: February 6, 2015Date of Patent: August 22, 2017Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: John P. Cooke, Eduard Yakubov
-
Patent number: 9719083Abstract: The present invention relates the use of broad range primer (e.g., as broad range capture olignucleotides) immobilized in a SCODA method gel to allow, for example, selective concentration of target nucleic acids. Such concentrated target nucleic acids may, for example, be: i) eluted from the gel and analyzed (e.g., by broad range primer methods); ii) subject to in situ (e.g., in gel) PCR methods; and/or iii) analyzed in the gel (e.g., by fluorescent detection methods).Type: GrantFiled: March 8, 2010Date of Patent: August 1, 2017Assignee: IBIS BIOSCIENCES, INC.Inventor: Steven A. Hofstadler
-
Patent number: 9714449Abstract: A nucleic acid amplification method includes ligating a double-stranded adapter (20) containing adapter DNA strands capable of forming a folded structure to a double-stranded DNA (1, 2) containing a target DNA sequence (1) to prepare a cyclic DNA template composed of double-stranded DNA containing a nick (5). A 3?-end elongation reaction is performed using a strand-displacement DNA polymerase from the nick (5) as an origin, thereby producing a concatemer (29) in which a plurality of the target DNA sequences (1) and the adapter DNA strands capable of forming the folded structure are linked in series as a single-stranded DNA. The concatemer (29) contains a plurality of the target DNA sequences (1) suitable for nucleotide sequence analysis and has a folded shape such that it takes the form of a ball due to its folded structure.Type: GrantFiled: November 22, 2012Date of Patent: July 25, 2017Assignee: Hitachi High-Technologies CorporationInventors: Yoshiaki Yazawa, Takahide Yokoi, Chihiro Uematsu
-
Patent number: 9708532Abstract: Multi-phase polymer films of quantum dots (QDs) are disclosed. The QDs are absorbed in a host matrix, which dispersed within an outer polymer phase. The host matrix is hydrophobic and is compatible with the surface of the QDs. The host matrix may also include a scaffolding material that prevents the QDs from agglomerating. The outer polymer is typically more hydrophilic and prevents oxygen from contacting the QDs.Type: GrantFiled: August 14, 2014Date of Patent: July 18, 2017Assignee: Nanoco Technologies Ltd.Inventors: Cong-Duan Vo, Imad Naasani, Amilcar Pillay Narrainen, Yien Ta, Emma Cherie Hogarth, Alexandra Shannon, Ross Jalmari Mera-Pirttijarvi, Elliot Stuart Poucher
-
Patent number: 9702002Abstract: The present invention relates to the field of molecular biology, and more specifically to methods for reducing the complexity of a nucleic acid sample.Type: GrantFiled: April 2, 2014Date of Patent: July 11, 2017Assignee: ILLUMINA, INC.Inventor: Jonathan Mark Boutell